Estradiol acetate

• Description :

  Estradiol acetate is a novel orally active Estradiol (HY-B0141) prodrug. Estradiol acetate reduces the frequency and severity of postmenopause symptoms. Estradiol acetate can be used in the research of menopausal symptoms[1][2].

• UNSPSC :

  12352005

• Hazard Statement :

  H315-H319-H320

• Target :

  Estrogen Receptor/ERR

• Related Pathways :

  Vitamin D Related/Nuclear Receptor

• Field of Research :

  Endocrinology

• Smiles :

  C[C@@]12[C@](CC[C@@H]2O)([H])[C@@]3([H])[C@@](CC1)([H])C4=CC=C(OC(C)=O)C=C4CC3

• Molecular Formula :

  C20H26O3

• Molecular Weight :

  314.42

• Precautions :

  P264-P280-P302+P352-P305+P351+P338-P362

• References & Citations :

  [1]Utian WH, et al. Comparative controlled trial of a novel oral estrogen therapy, estradiol acetate, for relief of menopause symptoms. Menopause. 2005 Nov-Dec;12 (6) :708-15. |[2]Speroff L, et al. Efficacy of a new, oral estradiol acetate formulation for relief of menopause symptoms. Menopause. 2006 May-Jun;13 (3) :442-50.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  Launched

• CAS Number :

  [4245-41-4]